synergistic antitumor effects immune cell-viral biotherapy 
targeted biological therapies hold tremendous potential treatment cancer yet use limited constraints delivery effective tumor targeting combined immune effector cell population [cytokine-induced killer cik cells] oncolytic viral therapy achieve directed delivery regression tumors immunodeficient immunocompetent mouse models preinfection cik cells modified vaccinia virus resulted prolonged eclipse phase virus remaining hidden interaction tumor whole-body imaging revealed cells retained ability traffic infiltrate tumor effectively releasing virus results illustrate potential combining biotherapeutics synergistic effects effectively treat cancer 
